NEW YORK (GenomeWeb News) - Swedish life sciences technology firm Biotage posted a 6 percent increase in third-quarter revenues yesterday, as a loss in the prior-year quarter swung into a profit.
 
Sales for the quarter ended Sept. 30 rose to SEK 133.9 million ($18 million) from SEK 126.6 million ($17.3 million) in the third quarter of 2005.
 
Revenues for the firm’s discovery chemistry business increased 7 percent, to SEK 111.5 million, while biosystems revenues were relatively flat at SEK 22.4 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.